NMFC Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Unchanged MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates on Strong Core Performance Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses RNG Q1 2026 Earnings EPS Beats Estimates Narrowly as Stock Pulls Back CCID Q1 2026 Earnings Preferred Shares Rise Despite Significant EPS Miss SYY Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines Slightly